Thu Jan 02 15:50:00 UTC 2025: ## Medicare to Cap Prescription Drug Costs at $2,000 Annually Starting January 1
**Washington, D.C.** – Beginning January 1, 2024, Medicare will implement a $2,000 annual cap on out-of-pocket prescription drug costs for beneficiaries, a move projected to significantly benefit millions of Americans. The measure, a key provision of the Inflation Reduction Act signed into law in 2022, is expected to provide substantial savings, particularly for seniors and those with chronic illnesses requiring multiple or expensive medications.
The AARP estimates that approximately 3.2 million Medicare recipients will see lower costs, with over 420,000 experiencing savings exceeding $3,000 by 2029. Total savings for these individuals are projected to surpass $1,000 annually.
The cap applies to individuals enrolled in Medicare Part D plans (covering most pharmaceuticals) and Medicare Advantage plans. However, coverage is limited to drugs listed on each plan’s formulary; medications not included will not be subject to the cap. The cap also does not include Part D premiums. It will cover deductibles, copayments, and coinsurance for eligible drugs.
This change addresses a long-standing concern regarding unpredictable and potentially crippling prescription drug expenses for Medicare beneficiaries. Prior to the Inflation Reduction Act, out-of-pocket spending was unlimited, leaving many vulnerable to substantial financial burdens.
The new cap is one of several cost-saving measures included in the act, following the recent implementation of a $35 cap on insulin for seniors. Experts are praising the change, citing the significant impact it will have on the financial well-being of many Medicare beneficiaries. A Department of Health and Human Services report estimated that if the cap had been in place in 2020, it would have saved beneficiaries an average of $500 annually on insulin alone.
First Piper 